Moolec Science (MLEC) Receivables (2022 - 2025)
Moolec Science's (MLEC) quarterly Receivables came in at $13.9 million in Q2 2025, down 94.32% year-on-year from $243.7 million in Q2 2024, and up 2349.23% quarter-over-quarter from -$615786.0 in Q4 2024.
Moolec Science (MLEC) Receivables (2022 - 2025) Analysis & Trends
Moolec Science has disclosed Receivables across 4 years of filings, most recently posting $13.9 million for Q2 2025.
- Receivables for Q2 2025 came in at $13.9 million, down 94.32% year-over-year; the trailing twelve-month figure through Jun 2025 was $13.9 million (down 94.32% YoY), and the FY2025 annual result was $13.9 million, up 2351.06% from the prior year.
- Receivables came in at $13.9 million for Q2 2025 at Moolec Science, up from -$615786.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $243.7 million in Q2 2024 to a low of -$615786.0 in Q4 2024.
- The 4-year median for Receivables is $12.2 million (2023), against an average of $36.8 million.
- Across the five-year window, Receivables tumbled 248.9% in 2023 and surged 133408.12% in 2024, its largest moves.
- Moolec Science's Receivables stood at $122754.0 in 2022, then surged by 9326.79% to $11.6 million in 2023, then sank by 105.32% to -$615786.0 in 2024, then soared by 2349.23% to $13.9 million in 2025.
- The last three Receivables figures came in at $13.9 million (Q2 2025), -$615786.0 (Q4 2024), and $13.2 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 13.85 Mn |
| Dec 31, 2024 | -615,786.00 |
| Sep 30, 2024 | 13.19 Mn |
| Jun 30, 2024 | 243.66 Mn |
| Mar 31, 2024 | 12.74 Mn |
| Dec 31, 2023 | 11.57 Mn |
| Jun 30, 2023 | -182,783.00 |
| Jun 30, 2022 | 122,754.00 |